12:00 AM
Feb 13, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Acorda, Watson sales and marketing update

Watson's Watson Pharma Inc. subsidiary launched in the U.S. an authorized generic of spasticity drug Zanaflex tizanidine from partner Acorda. The wholesale acquisition cost for 150...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >